Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05207085 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
A Phase 2 study of Trichotillomania (Hair-Pulling Disorder), sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05207085 is a Phase 2 study of Trichotillomania (Hair-Pulling Disorder) that is actively recruiting participants, run by Yale University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05207085, a Phase 2 study of Trichotillomania (Hair-Pulling Disorder), is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial aims to evaluate the efficacy, safety and tolerability of valbenazine, titrated to the subject's optimal dose of 40mg or 80mg, administered once daily, for 12 weeks, for the treatment of trichotillomania (TTM) in a double blind placebo controlled design study. After week 12, subjects will begin a 12-week, open-label portion of the study. During the open-label portion of the study, all subjects will receive the study drug at their optimal dose. The primary endpoint of these studies will be the change from baseline of placebo vs. active scores utilizing the Massachusetts General Hospital Hairpulling Scale (MGH-HPS) at the end of Week 12.
Conditions Studied
Interventions
- DRUG Valbenazine Oral Capsule
- OTHER Placebo Oral capsule
Study Locations (1)
Connecticut
- Yale Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2027-02-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05207085
The ClinicalTrials.gov registry entry for NCT05207085 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trichotillomania (Hair-Pulling Disorder) appearing as the primary indexed condition, and to 2 interventions - of which Valbenazine Oral Capsule is the first listed.
NCT05207085 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05207085 about?
NCT05207085 is a clinical study titled "Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults". This trial aims to evaluate the efficacy, safety and tolerability of valbenazine, titrated to the subject's optimal dose of 40mg or 80mg, administered once daily, for 12 weeks, for the treatment of trichotillomania (TTM) in a double blind placebo controlled design study. After week 12, subjects will...
What is the current status of trial NCT05207085?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2024-02-02. Estimated completion is 2027-02-15.
What conditions does trial NCT05207085 study?
This clinical trial studies the following conditions: Trichotillomania (Hair-Pulling Disorder).
What interventions are being tested in trial NCT05207085?
The interventions under investigation include: Valbenazine Oral Capsule (DRUG), Placebo Oral capsule (OTHER).
Who is sponsoring clinical trial NCT05207085?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05207085 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trichotillomania (Hair-Pulling Disorder)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.